BrioHealth secures FDA approval to launch BrioVAD system trial

​BrioHealth Solutions has secured conditional FDA approval to begin a clinical trial of its BrioVAD system in children diagnosed with advanced heart failure.

The post BrioHealth secures FDA approval to launch BrioVAD system trial appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

Nervonik closes $52.5m Series B funding to advance PNS system
Oruka reports positive data from Phase IIa trial for plaque psoriasis
FDA approves AstraZeneca’s Saphnelo for SLE
Sun Pharma to acquire Organon for $11.75bn
Kyowa Kirin and Kura initiate Phase II trial of ziftomenib for AML

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us